154 related articles for article (PubMed ID: 30737899)
1. Lung cancer imaging methods in China from 2005 to 2014: A national, multicenter study.
Hou DH; Zhao SJ; Shi JF; Wang L; Wang DB; Huang YC; Liao XZ; Xing XJ; Du LB; Yang L; Liu YQ; Zhang YZ; Wei DH; Liu YY; Zhang K; Li N; Chen WQ; Qiao YL; He J; Dai M; Wu N;
Thorac Cancer; 2019 Apr; 10(4):708-714. PubMed ID: 30737899
[TBL] [Abstract][Full Text] [Related]
2. Staging non-small cell lung cancer with whole-body PET.
Marom EM; McAdams HP; Erasmus JJ; Goodman PC; Culhane DK; Coleman RE; Herndon JE; Patz EF
Radiology; 1999 Sep; 212(3):803-9. PubMed ID: 10478250
[TBL] [Abstract][Full Text] [Related]
3. Coregistered whole body magnetic resonance imaging-positron emission tomography (MRI-PET) versus PET-computed tomography plus brain MRI in staging resectable lung cancer: comparisons of clinical effectiveness in a randomized trial.
Yi CA; Lee KS; Lee HY; Kim S; Kwon OJ; Kim H; Choi JY; Kim BT; Hwang HS; Shim YM
Cancer; 2013 May; 119(10):1784-91. PubMed ID: 23423920
[TBL] [Abstract][Full Text] [Related]
4. Positron emission tomography in staging early lung cancer: a randomized trial.
Maziak DE; Darling GE; Inculet RI; Gulenchyn KY; Driedger AA; Ung YC; Miller JD; Gu CS; Cline KJ; Evans WK; Levine MN
Ann Intern Med; 2009 Aug; 151(4):221-8, W-48. PubMed ID: 19581636
[TBL] [Abstract][Full Text] [Related]
5. Fluorine-18 deoxyglucose positron emission tomography, magnetic resonance imaging and bone scintigraphy for the diagnosis of bone metastases in patients with lung cancer: which one is the best?--a meta-analysis.
Liu T; Xu JY; Xu W; Bai YR; Yan WL; Yang HL
Clin Oncol (R Coll Radiol); 2011 Jun; 23(5):350-8. PubMed ID: 21094027
[TBL] [Abstract][Full Text] [Related]
6. Pure ground glass nodular adenocarcinomas: Are preoperative positron emission tomography/computed tomography and brain magnetic resonance imaging useful or necessary?
Cho H; Lee HY; Kim J; Kim HK; Choi JY; Um SW; Lee KS
J Thorac Cardiovasc Surg; 2015 Sep; 150(3):514-20. PubMed ID: 26189165
[TBL] [Abstract][Full Text] [Related]
7. Screening for brain metastases in patients with stage III non-small cell lung cancer: Is there additive value of magnetic resonance imaging above a contrast-enhanced computed tomography of the brain?
Hendriks LE; Bootsma GP; de Ruysscher DK; Scheppers NA; Hofman PA; Brans BT; Dingemans AM
Lung Cancer; 2013 Jun; 80(3):293-7. PubMed ID: 23518381
[TBL] [Abstract][Full Text] [Related]
8. Imaging for the Pretreatment Staging of Small cell Lung Cancer: A Systematic Review.
Mitchell MD; Aggarwal C; Tsou AY; Torigian DA; Treadwell JR
Acad Radiol; 2016 Aug; 23(8):1047-56. PubMed ID: 27259379
[TBL] [Abstract][Full Text] [Related]
9. Imaging modalities for the staging of patients with colorectal cancer.
Bipat S; Niekel MC; Comans EF; Nio CY; Bemelman WA; Verhoef C; Stoker J
Neth J Med; 2012 Jan; 70(1):26-34. PubMed ID: 22271811
[TBL] [Abstract][Full Text] [Related]
10. Variabilities of Magnetic Resonance Imaging-, Computed Tomography-, and Positron Emission Tomography-Computed Tomography-Based Tumor and Lymph Node Delineations for Lung Cancer Radiation Therapy Planning.
Karki K; Saraiya S; Hugo GD; Mukhopadhyay N; Jan N; Schuster J; Schutzer M; Fahrner L; Groves R; Olsen KM; Ford JC; Weiss E
Int J Radiat Oncol Biol Phys; 2017 Sep; 99(1):80-89. PubMed ID: 28816167
[TBL] [Abstract][Full Text] [Related]
11. Diagnostic Imaging and Newer Modalities for Thoracic Diseases: PET/Computed Tomographic Imaging and Endobronchial Ultrasound for Staging and Its Implication for Lung Cancer.
Counts SJ; Kim AW
PET Clin; 2018 Jan; 13(1):113-126. PubMed ID: 29157382
[TBL] [Abstract][Full Text] [Related]
12. Diagnostic performance of different imaging modalities in the assessment of distant metastasis and local recurrence of tumor in patients with non-small cell lung cancer.
Ohno Y; Yoshikawa T; Kishida Y; Seki S; Koyama H; Yui M; Kassai Y; Aoyagi K; Kaminaga S; Sugimura K
J Magn Reson Imaging; 2017 Dec; 46(6):1707-1717. PubMed ID: 28419645
[TBL] [Abstract][Full Text] [Related]
13. Noninvasive staging of non-small cell lung cancer: a review of the current evidence.
Toloza EM; Harpole L; McCrory DC
Chest; 2003 Jan; 123(1 Suppl):137S-146S. PubMed ID: 12527573
[TBL] [Abstract][Full Text] [Related]
14. Routine preoperative brain CT in resectable non-small cell lung cancer - Ten years experience from a tertiary UK thoracic center.
Matys T; Drury R; David S; Rassl DM; Qian W; Rintoul RC; Screaton NJ
Lung Cancer; 2018 Aug; 122():195-199. PubMed ID: 30032831
[TBL] [Abstract][Full Text] [Related]
15. Contribution of magnetic resonance imaging in lung cancer imaging.
Khalil A; Majlath M; Gounant V; Hess A; Laissy JP; Debray MP
Diagn Interv Imaging; 2016 Oct; 97(10):991-1002. PubMed ID: 27693089
[TBL] [Abstract][Full Text] [Related]
16. Diagnostic Imaging and Newer Modalities for Thoracic Diseases: PET/Computed Tomographic Imaging and Endobronchial Ultrasound for Staging and Its Implication for Lung Cancer.
Counts SJ; Kim AW
Surg Clin North Am; 2017 Aug; 97(4):733-750. PubMed ID: 28728712
[TBL] [Abstract][Full Text] [Related]
17. Non-small-cell lung cancer: practice patterns of extrathoracic imaging.
Wong J; Haramati LB; Rozenshtein A; Yanez M; Austin JH
Acad Radiol; 1999 Apr; 6(4):211-5. PubMed ID: 10894078
[TBL] [Abstract][Full Text] [Related]
18. Economic Benefits and Diagnostic Quality of Diffusion-Weighted Magnetic Resonance Imaging for Primary Lung Cancer.
Usuda K; Funazaki A; Maeda R; Sekimura A; Motono N; Matoba M; Uramoto H
Ann Thorac Cardiovasc Surg; 2017 Dec; 23(6):275-280. PubMed ID: 28978865
[TBL] [Abstract][Full Text] [Related]
19. Imaging in lung cancer.
Sarinas PS; Chitkara RK; Rizk NW; Segall GM; Stark P
Curr Opin Pulm Med; 1996 Jul; 2(4):263-70. PubMed ID: 9363150
[TBL] [Abstract][Full Text] [Related]
20. Optimal imaging protocols for lung cancer staging: CT, PET, MR imaging, and the role of imaging.
Paul NS; Ley S; Metser U
Radiol Clin North Am; 2012 Sep; 50(5):935-49. PubMed ID: 22974779
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
